ADMA Biologics Inc (ADMA)
21.15
-0.15
(-0.70%)
USD |
NASDAQ |
Nov 22, 10:07
ADMA Biologics Total Assets (Quarterly): 390.62M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 390.62M |
| June 30, 2024 | 376.40M |
| March 31, 2024 | 350.88M |
| December 31, 2023 | 329.18M |
| September 30, 2023 | 349.00M |
| June 30, 2023 | 343.03M |
| March 31, 2023 | 340.79M |
| December 31, 2022 | 348.46M |
| September 30, 2022 | 300.56M |
| June 30, 2022 | 296.93M |
| March 31, 2022 | 308.03M |
| December 31, 2021 | 276.25M |
| September 30, 2021 | 238.64M |
| June 30, 2021 | 232.81M |
| March 31, 2021 | 235.67M |
| December 31, 2020 | 207.67M |
| September 30, 2020 | 189.98M |
| June 30, 2020 | 191.54M |
| March 31, 2020 | 210.52M |
| December 31, 2019 | 127.09M |
| September 30, 2019 | 137.78M |
| June 30, 2019 | 143.27M |
| March 31, 2019 | 78.12M |
| December 31, 2018 | 88.88M |
| September 30, 2018 | 106.35M |
| Date | Value |
|---|---|
| June 30, 2018 | 117.75M |
| March 31, 2018 | 91.14M |
| December 31, 2017 | 108.02M |
| September 30, 2017 | 72.81M |
| June 30, 2017 | 84.64M |
| March 31, 2017 | 17.59M |
| December 31, 2016 | 23.69M |
| September 30, 2016 | 27.50M |
| June 30, 2016 | 31.74M |
| March 31, 2016 | 19.68M |
| December 31, 2015 | 23.71M |
| September 30, 2015 | 27.82M |
| June 30, 2015 | 29.80M |
| March 31, 2015 | 33.93M |
| December 31, 2014 | 27.02M |
| September 30, 2014 | 25.29M |
| June 30, 2014 | 27.88M |
| March 31, 2014 | 31.95M |
| December 31, 2013 | 31.98M |
| September 30, 2013 | 8.702M |
| June 30, 2013 | 10.69M |
| March 31, 2013 | 13.82M |
| December 31, 2012 | 15.56M |
| September 30, 2012 | 13.22M |
| June 30, 2012 | 15.88M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
127.09M
Minimum
Dec 2019
390.62M
Maximum
Sep 2024
282.20M
Average
298.74M
Median
Total Assets (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 784.26M |
| Madrigal Pharmaceuticals Inc | 1.073B |
| Assembly Biosciences Inc | 100.26M |
| TG Therapeutics Inc | 586.01M |
| Krystal Biotech Inc | 982.32M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 158.73M |
| Shareholders Equity (Quarterly) | 231.89M |
| Debt to Equity Ratio | 0.437 |
| Current Ratio | 7.088 |
| Net Debt Paydown Yield | 0.16% |